Valproic acid enhances glucose transport in the cultured brain astrocytes of glucose transporter 1 heterozygous mice. Academic Article uri icon

Overview

abstract

  • Glucose transporter 1 facilitates glucose transport across the blood-brain barrier. By increasing histone acetylation at the SLC2A1 promotor, valproic acid could increase SLC2A1 gene expression. This study was designed to evaluate the effects of valproic acid on glucose transport in astrocyte cultures derived from SLC2A1 heterozygous mice. Primary astrocyte cultures were prepared from the cerebral cortex of 1-day-old neonatal mice. Cultured astrocytes were incubated with valproic acid (0.05, 0.5, and 5 mM) for 48 hours. On day 3, the glucose uptake capacity of the astrocytes was measured by using (14)C-2-Deoxy-d-glucose under zero-trans conditions. The heterozygous astrocyte glucose uptake treated with valproic acid (0.05 and 0.5 mM) for 48 hours was significantly increased compared with the untreated control heterozygous astrocytes. Our findings demonstrate that valproic acid increased glucose transport capacity in SLC2A1 heterozygous cerebral astrocytes.

publication date

  • April 24, 2012

Research

keywords

  • Anticonvulsants
  • Astrocytes
  • Brain
  • Glucose Transporter Type 1
  • Valproic Acid

Identity

Scopus Document Identifier

  • 84871530765

Digital Object Identifier (DOI)

  • 10.1177/0883073812440044

PubMed ID

  • 22532550

Additional Document Info

volume

  • 28

issue

  • 1